Acquisition Talks and Market Impact Advent Capital and Blackstone‑backed Aster DM Quality Care are reportedly close to completing due diligence for a controlling stake in Yatharth Hospital and Trauma Care Services. The bid could trigger an open offer for an additional 26% of the company, potentially elevating the acquirer’s share to over 75%. Yatharth’s shares have surged 15.3% in the last month, reaching a fresh 52‑week high of ₹982.65 and a valuation of ₹9,462 crore. On August 28, the stock traded 4.5% higher at ₹1,018.5, reflecting investor optimism amid the acquisition chatter.
Yatharth’s Growth Trajectory Yatharth, headquartered in Noida and Greater Noida, operates nine hospitals with a combined capacity of 2,800 beds and plans to expand to 5,000 beds over the next three years. The first‑quarter FY26 results showed a 51% YoY revenue rise to ₹392.70 crore, while average revenue per occupied bed climbed 7% to ₹34,758. The company projects a 24%+ EBITDA margin in FY27 and anticipates a 37% FY26 growth that could be surpassed in FY27.
Aster DM’s Strategic Vision Aster DM Quality Care, formed by merging Aster DM Healthcare and Quality Care India, currently runs about 40 hospitals across 27 cities. With a market capitalisation of ₹65,828.70 crore, the firm has outperformed the Nifty this year, gaining 22.36% versus an 8% decline in the benchmark. The potential Yatharth acquisition would give Aster a stronger presence in North and Central India—areas where its footprint is limited. Aster’s Executive Director, Alisha Moopen, envisions expanding bed capacity to 15,000 by FY29 and becoming the largest listed hospital company in India within 3–4 years.
Both entities see operational synergies: Yatharth’s focus on robotics, oncology and transplant programmes aligns with Aster’s specialty capabilities, offering a path to rapid pan‑India expansion while maintaining high EBITDA margins.